Clinical Trial Update: Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of a single-dose intranasal sumatriptan powder delivered via a bi-directional device in adults with acute migra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

Sponsor: Optinose US Inc. | Conditions: Migraine Headache | Phase 3 | Status: COMPLETED | Results posted: 2015-05-06